Lifeward (LFWD) Competitors $0.73 -0.02 (-2.55%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$0.72 -0.01 (-1.38%) As of 08:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFWD vs. VVOS, OSRH, BDMD, FEMY, NXGL, RVP, NRXS, ALUR, PETV, and CLGNShould you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include Vivos Therapeutics (VVOS), OSR (OSRH), Baird Medical Investment (BDMD), Femasys (FEMY), NexGel (NXGL), Retractable Technologies (RVP), NeurAxis (NRXS), Allurion Technologies (ALUR), PetVivo (PETV), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry. Lifeward vs. Its Competitors Vivos Therapeutics OSR Baird Medical Investment Femasys NexGel Retractable Technologies NeurAxis Allurion Technologies PetVivo CollPlant Biotechnologies Vivos Therapeutics (NASDAQ:VVOS) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends. Does the media refer more to VVOS or LFWD? In the previous week, Vivos Therapeutics and Vivos Therapeutics both had 1 articles in the media. Lifeward's average media sentiment score of 1.89 beat Vivos Therapeutics' score of 1.87 indicating that Lifeward is being referred to more favorably in the news media. Company Overall Sentiment Vivos Therapeutics Very Positive Lifeward Very Positive Which has more volatility and risk, VVOS or LFWD? Vivos Therapeutics has a beta of 7.01, indicating that its stock price is 601% more volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.02, indicating that its stock price is 98% less volatile than the S&P 500. Which has higher earnings and valuation, VVOS or LFWD? Vivos Therapeutics has higher earnings, but lower revenue than Lifeward. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVivos Therapeutics$15.03M2.64-$11.14M-$1.73-3.90Lifeward$25.41M0.31-$28.94M-$3.04-0.24 Do insiders & institutionals have more ownership in VVOS or LFWD? 26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 26.8% of Lifeward shares are owned by institutional investors. 3.0% of Vivos Therapeutics shares are owned by insiders. Comparatively, 2.7% of Lifeward shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend VVOS or LFWD? Vivos Therapeutics presently has a consensus target price of $4.82, indicating a potential downside of 28.54%. Lifeward has a consensus target price of $9.00, indicating a potential upside of 1,139.67%. Given Lifeward's stronger consensus rating and higher probable upside, analysts plainly believe Lifeward is more favorable than Vivos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivos Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Lifeward 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is VVOS or LFWD more profitable? Vivos Therapeutics has a net margin of -76.82% compared to Lifeward's net margin of -108.21%. Lifeward's return on equity of -101.96% beat Vivos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vivos Therapeutics-76.82% -170.43% -77.82% Lifeward -108.21%-101.96%-70.49% SummaryLifeward beats Vivos Therapeutics on 9 of the 15 factors compared between the two stocks. Get Lifeward News Delivered to You Automatically Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFWD vs. The Competition Export to ExcelMetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$8.20M$18.07B$27.98B$9.29BDividend YieldN/A2.77%3.14%4.03%P/E Ratio-0.2473.4633.0119.58Price / Sales0.3168.291,765.7694.56Price / CashN/A91.8837.6457.93Price / Book0.348.467.465.54Net Income-$28.94M$337.83M$779.73M$257.73M7 Day Performance-5.71%-1.25%-0.66%-0.08%1 Month Performance-33.39%5.09%4.90%8.09%1 Year Performance-81.53%43.01%52,715.15%13.02% Lifeward Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFWDLifeward2.6613 of 5 stars$0.73-2.6%$9.00+1,139.7%-81.4%$8.20M$25.41M-0.2460Positive NewsVVOSVivos Therapeutics1.2964 of 5 stars$5.17+16.7%$4.82-6.8%+141.6%$26.09M$15.03M-2.99160Positive NewsHigh Trading VolumeOSRHOSRN/A$1.33-1.5%N/AN/A$26.02M-$148.95K0.00N/ABDMDBaird Medical InvestmentN/A$4.06+3.8%N/AN/A$25.74MN/A0.00N/AAnalyst DowngradeGap DownFEMYFemasys2.8758 of 5 stars$0.93-0.2%$8.67+832.6%-16.7%$23.80M$1.70M-1.0230NXGLNexGel0.7045 of 5 stars$2.64-0.4%N/A+17.3%$20.28M$8.69M-5.8710Gap UpRVPRetractable Technologies0.9644 of 5 stars$0.66+1.2%N/A-43.4%$19.69M$33.75M-1.22240Positive NewsNRXSNeurAxis2.6644 of 5 stars$2.70+4.7%$7.00+159.3%-18.3%$19.48M$2.93M-1.4719ALURAllurion Technologies2.9647 of 5 stars$2.57+2.4%$22.83+788.5%-87.4%$18.72M$32.11M-0.21501PETVPetVivoN/A$0.75-3.8%N/A+53.7%$18.21M$1.05M-1.6720CLGNCollPlant Biotechnologies2.3828 of 5 stars$1.35-2.4%$11.50+751.9%-65.8%$17.60M$510K-1.1170 Related Companies and Tools Related Companies Vivos Therapeutics Competitors OSR Competitors Baird Medical Investment Competitors Femasys Competitors NexGel Competitors Retractable Technologies Competitors NeurAxis Competitors Allurion Technologies Competitors PetVivo Competitors CollPlant Biotechnologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFWD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifeward Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifeward With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
